XML 114 R99.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings per Share - Schedule of Computation of Basic and Diluted Income Attributable to Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Numerator      
Net Income $ 88,131 $ 14,458,911 $ 185,179
Less: Income (loss) attributable to non-controlling interests (25,735) 5,991,431 74,810
Net income attributable to shareholders of Sinovac 113,866 8,467,480 110,369
Less: Preferred stock dividends 5,982 5,982 6,015
Net income attributable to common shareholders of Sinovac 107,884 8,461,498 104,354
Net income attributable to shareholders of Sinovac for computing diluted net income per share $ 113,866 $ 8,467,480 $ 110,369
Denominator      
Basic weighted average number of common shares outstanding 99,502,243 99,311,551 98,897,345
Dilutive effect of stock options and preferred shares 14,670,539 14,694,432 14,765,017
Diluted weighted average number of common shares outstanding 114,172,782 114,005,983 113,662,362
Earnings per share      
Basic net income per share $ 1.08 $ 85.20 $ 1.06
Diluted net income per share $ 1.00 $ 74.27 $ 0.97